Homology Medicines Cash from Operations (TTM) Analysis

Homology Medicines Inc (DELISTED) (FIXX:DL)

0.9347 -15.76 (-94.40%) USD | NASDAQ | Mar 25, 16:00

0.92 -0.01 (-1.57%) After-Hours: 20:00

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	-96.23M
September 30, 2023	-101.85M
June 30, 2023	-101.84M
March 31, 2023	-109.03M
December 31, 2022	-113.66M
September 30, 2022	-116.89M
June 30, 2022	-117.35M
March 31, 2022	-110.61M
December 31, 2021	-109.75M
September 30, 2021	-90.93M
June 30, 2021	-94.43M
March 31, 2021	-98.31M
December 31, 2020	-94.33M

Date	Value
September 30, 2020	-109.05M
June 30, 2020	-105.65M
March 31, 2020	-99.33M
December 31, 2019	-91.36M
September 30, 2019	-73.10M
June 30, 2019	-61.31M
March 31, 2019	-49.39M
December 31, 2018	-42.56M
September 30, 2018	-12.44M
June 30, 2018	-4.192M
March 31, 2018	-0.0402M
December 31, 2017	6.479M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-117.35M

Minimum

Jun 2022

-61.31M

Maximum

Jun 2019

-99.74M

Average

-101.84M

Median

Jun 2023

Cash from Operations (TTM) Benchmarks